Vivos Inc (QB) (RDGL)

You keep repeating "negative margins" as if businesses never improve economics over time. The awkward part is ignoring the obvious operational changes that affect cost structure.

The logic here seems to be: "it wasn't profitable before, therefore it can never be profitable." That's not analysis. That's fortune telling dressed up as certainty.

The conclusion assumes static conditions indefinitely. Business economics can change through scale, process improvements, manufacturing efficiencies, and operational restructuring.

The argument treats current economics as permanent while overlooking potential future changes in production, supply chain, and cost controls. That assumption is not self-evidently valid.

Wow wee... did you find that all by yourself just like a big kid?

A little more than  3 weeks until the IDE decision. An approval will start human trials at the Mayo Clinic . IsoPet gaining traction . Over 1200% increase year over year . Let’s not forget the DCGI in India and the licensing potential of PrecisionGel .This share price won’t last . Neither will the bashers .

Your denials that Isopet, launched a decade ago, is still sold below cost, doesn't change the fact that is indeed the case. The margins are negative. Over ten years is more than enough time to conclude there is no market to sell IsoPet at a profit. It's a hopeless dead end distraction just meant to string suckers along.

Just keeping it real

Yes and I've been posting ISOPET Now....

Then RDGL soon enough imo....its finally becoming reality despite what the bashers say or post....

Let's go ISOPET now and RDGL soon enough imo....July can't come fast enough lol

This one has to hurt.👋

Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™ (PRnT) for the treatment of cancerous tumors, is pleased to announce that it has received its State of Washington Radioactive Materials License for the manufacturing of IsoPet®.

Finally, you've come to realize bragging that AI does all of your thinking for you is not such a great or credible look. At least dropping the "I couldn't understand what you are talking about" lead in is a slight improvement. Go rdgl... this juggernaut can't be stopped... maybe.

I’m thinking announcement before July 4. 

Statements like this explain why some people shouldn't discuss margins. The sentence sounds dramatic, but it falls apart the moment you think about it.

This is one of those posts where confidence and accuracy are moving in opposite directions. The more certain the wording, the less sense it makes.

The argument contains an internal contradiction. The conclusion does not logically follow from the premise presented.

The statement appears to confuse several different concepts and arrives at a conclusion that is not supported by its own reasoning.

Oh yes, the old deliberate misleading FDA approval nonsense. Radiogel is nowhere near FDA approval.

Saddest part about that is IsoPet margins are negative. Doubling the margins just digs hole to bankruptcy twice as fast.

I admit I was wrong but maybe that will be the date they announce
approval LOL

Boy o boy I cant tell ya hw happy I am u were wrong abt the sub date. lol

Really liking the incremental PPS rise and am expecting (more hoping) this trend continues into the FDA decision. Not saying I would mind if it went parabolic but that just creates volatility I don't think the company needs or wants at this critical point. GLTA, especially the true Longs.

Closing in on July 4th fireworks imo...

Let's go ISOPET now and RDGL soon enough....

Bid moving up..

Bid moving up..

I have always been of the opinion that it take as long as 3 days to REALLY SHOW UP and be reflected in a shares pricing let's see if that holds here this time as well.

Here's the final numbers for today:

Buy: 360,624 Neutral: 20,081 Sell: 108,714

yes.. waiting for a transaction to clear and will add while it's in the 6's.

Today's Buy/Sell volume so far........
Buy: 351,002. Neutral: 20,081. Sell: 65,110

Icebergs(hidden ask amounts) are being put up imo to keep the sp from moving up.
I think the MM's know what's coming.
24 days or less until the IDE decision.

This is all very exciting - it is methodical, clearly thought out and has the support of the subject matter expert overseeing the submission. GOOOOOO RDGL!

Agree.  It’s always been about IDE approval and starting EFS/Trials at Mayo and other locations.  Today’s PR is good, but it will have much more weight and significance after IDE approval. 

The market's interested in a successful IDE and the start of trials, not abt some approval to produce Ytt at some future date. I would've thought a seasoned pro like you would know that, but guess what...nobody likewise gives a crap abt goofy complain-ikins either so there.

Some here are true longs who actually own shares.
Some are here to bash and pretend to own shares.
24 days or less until the IDE decision.
I like our odds for an approval.

BINGO ...kinda makes you wonder who the bashers are in real life lol
Some just like to whine but not dine....

Well the dining table is being set and dinner is going to be ready soon. Hopefully it's going to be about a 17 course meal in time.
Just a little more Patience for the cancer patients.

Let's go ISOPET now and RDGL soon enough...imo

JS submitted the EFS IDE as the best option for success so some random goof whining abt it is worthless trash. Clearer now!?

Why would I be sad that their Isopet margins will most likely double when they manufacture in-house?

I will be very happy.

Very confusing!!!!!!!

JUST RELEASED NEWS:
Vivo Inc is pleased to announce the receipt of the Washington State Radioactive Materials License for IsoPet® Manufacturing which clears the way for in-house production at Vivos’ new domestic manufacturing facility. $RDGL

RDGL

Don't be sad that their Isopet margins will most likely double when they manufacture in-house.

Obviously stock price won’t move up without FDA approval at this time
Even then we won’t see that much of a sustained increase
RDGL needs human clinical success

Very confusing.

I make a comment about the marketplace not caring about the news, and you post to me, "Don't be sad that their Isopet margins will most likely double when they manufacture in-house.

You lose."

Very confusing.

Seriously?

In all caps?

It's always manipulation its seems. Not lacking of buying pressure. Not selling pressure.

Manipulation.

Okay...............

Because nobody gives a chit. Not my opinion, the marketplaces opinion.

SAME AS ALWAYS MANIPULATION

Thank you!

This is huge news imo....2nd half 2026 is going to have fireworks on display imo

Shifting gears to a faster pace....

Let's go ISOPET now and RDGL soon enough

This is big news imo.
Don't understand why RDGL is down slightly today.
Any ideas?

Augster
I would suggest that since ISOPET is already in use their goal was only to have a RADIO ACTIVE PRODUCTION license so they could then inhouse manufacture and legally handle/possess the RADIO ACTIVE MATERIAL

Makes sense, Thanks

My guess is IsoPet is already commercially available and used so makes sense in the sequential licensing process to get IsoPet licensed first, then come back for RadiGel as it’s still in the preliminary pre-clinical stage.

CatFish, is there a reason why they didn't apply for RadioGel at the same time, or had to one at a time? Do you see any issues receiving a license for RadioGel? Thanks

NEWS -- Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing



Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™ (PRnT) for the treatment of cancerous tumors, is pleased to announce that it has received its State of Washington Radioactive Materials License for the manufacturing of IsoPet®.

This approval represents a significant regulatory milestone for the Company’s animal health division. It clears the way for in-house production of IsoPet® at Vivos’ new domestic manufacturing facility located at the Applied Process Engineering Laboratory (APEL) in Richland, Washington.

“We are thrilled to achieve this key milestone,” said David Swanberg, Chief Operating Officer of Vivos Inc. “Securing the Washington State Radioactive Materials License enables us to establish reliable, compliant domestic manufacturing capabilities. This is a critical step forward in our efforts to scale production and meet the growing demand from veterinarians and pet owners across the country for our innovative, same-day cancer therapy for animals.”

Now that the IsoPet Radioactive Materials License has been granted, Vivos will immediately apply for an amendment to add RadioGel® to the license. This amendment will support clinical trials in the United States and, as necessary, internationally.

With the license now in hand, Vivos anticipates shipping its first production run in the near future. This will support the continued expansion of certified IsoPet® treatment centers nationwide and help accelerate access to this non-invasive, non-surgical, and highly targeted therapy for companion animals and horses suffering from solid tumors.

IsoPet® delivers a high therapeutic dose of Yttrium-90 directly into the tumor, providing a precise, effective treatment option with minimal impact on surrounding healthy tissue. The Company continues to see strong interest and adoption growth in its animal therapy division.

About Vivos Inc.

Vivos Inc. is developing advanced Yttrium-90 based brachytherapy devices for the treatment of tumors in both animals (IsoPet®) and humans (RadioGel®). The Company is committed to delivering safer, more effective, and accessible cancer therapies through Precision Radionuclide Therapy™.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of applicable securities laws. Actual results may differ materially from those expressed or implied due to various risks and uncertainties.

Contact:

Mike Korenko, ScD
CEO, Vivos Inc.
mailto://mkorenko@radiogel.com

Brad Weeks
President, Vivos Inc.
mailto://brad.weeks@vivosinc.com

Follow Vivos Inc. on X (Twitter): @VivosIncUSA

Learn more about RadioGel® and IsoPet® at https://www.VivosInc.com

Vivos Inc is pleased to announce the receipt of the Washington State Radioactive Materials License for IsoPet® Manufacturing which clears the way for in-house production at Vivos’ new domestic manufacturing facility. $RDGL https://t.co/SYUj8N0IFb— Vivos Inc. (@VivosIncUSA) June 11, 2026

Bought a few k 2 days ago

Long been Long for too Long
Can’t see buying more until after FDA approval
The way this stock reacts after good news
Probably stay under 15 cents
Hope i’m wrong

Anyone else buying here besides me and skate and SS?
I see value.
EFS IDE resub with the help of Dr John Smith..
I like their odds for approval.

And that’s been the confusion with many, including us.  Either MK failed to use consistent language in the submission PRs or the submissions between 2021 this most recent were in fact full IDE and not EFS IDE.  As outsiders, we don’t know with any certainty.